Tim M J Ewoldt

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Machine Learning

Cardiovascular Disease

Top Venues

Antibiotics (Basel, Switzerland)

Intensive care medicine

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Dräger, Tim M J Ewoldt, Alan Abdulla, Wim J R Rietdijk, Nelianne J Verkaik, Christian Ramakers, Evelien de Jong, Michael Osthoff, Birgit C P Koch, Henrik Endeman, null null
Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics 16 (2) (2024)
Sarah Dräger, Tim M J Ewoldt, Alan Abdulla, Wim J R Rietdijk, Nelianne J Verkaik, Christian Ramakers, Evelien de Jong, Michael Osthoff, Birgit C P Koch, Henrik Endeman, null null
Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics 16 (2) (2024)
Letao Li, Sebastiaan D T Sassen, Tim M J Ewoldt, Alan Abdulla, Nicole G M Hunfeld, Anouk E Muller, Brenda C M de Winter, Henrik Endeman, Birgit C P Koch
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It? Antibiotics (Basel, Switzerland) 12 (2) (2023)
Letao Li, Sebastiaan D T Sassen, Tim M J Ewoldt, Alan Abdulla, Nicole G M Hunfeld, Anouk E Muller, Brenda C M de Winter, Henrik Endeman, Birgit C P Koch
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It? Antibiotics (Basel, Switzerland) 12 (2) (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Letao Li, Sebastiaan D T Sassen, Tim M J Ewoldt, Alan Abdulla, Nicole G M Hunfeld, Anouk E Muller, Brenda C M de Winter, Henrik Endeman, Birgit C P Koch
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It? Antibiotics (Basel, Switzerland) 12 (2) (2023)
Tim M J Ewoldt, Alan Abdulla, Anouk E Muller, Henrik Endeman, Birgit C P Koch, null null
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter. Author's reply. Intensive care medicine (2023)
Tim M J Ewoldt, Soma Bahmany, Alan Abdulla, Anouk E Muller, Henrik Endeman, Birgit C P Koch
Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions? The Journal of antimicrobial chemotherapy (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Tim M J Ewoldt, Alan Abdulla, Wim J R Rietdijk, Anouk E Muller, Brenda C M de Winter, Nicole G M Hunfeld, Ilse M Purmer, Peter van Vliet, Evert-Jan Wils, Jasper Haringman, Annelies Draisma, Tom A Rijpstra, Attila Karakus, Diederik Gommers, Henrik Endeman, Birgit C P Koch
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive care medicine 48 (12) (2022)